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Pertussis toxin was used to examine the role of the inhibitory guanine nucleotide
regulatory protein, Ni, in muscarinic-receptor-mediated stimulation of phosphoinosi-
tide turnover and calcium mobilization. In cultured chick heart cells, pertussis-toxin
treatment inhibited muscarinic-receptor-mediated attenuation of isoprenaline-
stimulated cyclic AMP accumulation. This finding is consistent with the proposal
that pertussis toxin blocks the capacity of Ni to couple muscarinic receptors to
adenylate cyclase. In contrast, treatment of chick heart cells or 1321 NI human
astrocytoma cells with pertussis toxin did not block muscarinic-receptor-mediated
stimulation of phosphoinositide hydrolysis, -as measured by [3H]inositol phosphate
accumulation in the presence of Li+. Pertussis-toxin treatment also had little effect on
basal and muscarinic-receptor-stimulated phosphatidylinositol synthesis, as
measured by the incorporation of [3H]inositol into phosphatidylinositol. Activation
of muscarinic receptors also enhances the rate of unidirectional 45Ca2+ efflux in
1321 NI cells; this response, like phosphoinositide hydrolysis, was not prevented by
pertussis-toxin treatment. Our data suggest that muscarinic receptors are not coupled
to phosphoinositide hydrolysis or calcium mobilization through Ni.
Insight into the molecular basis of hormonal
regulation of adenylate cyclase was advanced by
the discovery of a pair of guanine nucleotide
regulatory proteins that couple agonist-occupied
receptors to the catalytic component of adenylate
cyclase. Stimulatory hormone receptors catalyse
the exchange of GTP for GDP on the regulatory
protein, Ns, which in turn interacts with the
catalytic protein to form the active enzymic species
(Ross & Gilman, 1980; Rodbell, 1980; Gilman,
1984). Receptor-mediated inhibition of adenylate
cyclase involves the coupling function of another
protein, Ni, which shares a number of structural
and functional similarities with N.. A toxin
Abbreviations used: InsP, inositol phosphate; PtdIns,
phosphatidylinositol; Ni, the guanine nucleotide regula-
tory protein that couples inhibitory receptors to adenyl-
ate cyclase; N., the guanine nucleotide regulatory
protein that couples stimulatory receptors to adenylate
cyclase.
$ Present address: Department of Pharmacology,
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purified from Bordetella pertussis (pertussis toxin)
catalyses the ADP-ribosylation of the 41 0O0-M, a-
subunit of N, (Kurose et al., 1983; Gilman, 1984;
Katada et al., 1984). This action correlates with the
capacity of pertussis toxin to block agonist-
mediated inhibition of adenylate cyclase (Katada
& Ui, 1980; Hazeki & Ui, 1981; Kurose et al.,
1983; Gilman, 1984; Katada et al., 1984).
Several hormones that inhibit adenylate cyclase
also increase the turnover of membrane phos-
phoinositides and cause calcium mobilization
(Michell, 1975; Berridge, 1981; Brown & Brown,
1984). In contrast with the adenylate cyclase
system, little is known about the molecular
mechanisms by which receptor occupation leads to
these other responses. An important question is
whether a guanine nucleotide regulatory protein is
involved in hormonal regulation of phosphoinosi-
tide turnover. There is indirect evidence in support
of this possibility: guanine nucleotides regulate
agonist affinity for receptors that are apparently
coupled to phosphoinositide hydrolysis and cal-
cium mobilization (Snavely & Insel, 1982; Koo et
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al., 1983; Boyer et al., 1984; Evans et al., 1985), and
guanine nucleotides affect calcium mobilization
and diacylglycerol formation in permeabilized
cells (Gomperts, 1983; Haslam & Davidson, 1984).
Additionally, pertussis toxin has been proposed to
act as a calcium ionophore (Katada & Ui, 1979)
and more recently shown to block calcium mobili-
zation and related responses induced by chemo-
tactic factors in neutrophils (Okajima & Ui, 1984;
Molski et al., 1984; Bokoch & Gilman, 1984). Ni
has also been implicated in hormal regulation of
phosphoinositide turnover by Moreno et al. (1983),
who reported that treatment of rats with pertussis
toxin inhibits al-adrenergic-receptor-stimulated
phosphoinositide synthesis in adipocytes, as
measured by [32p]p; incorporation into phosphati-
dic acid and PtdIns.
In the studies described here pertussis toxin
was utilized to evaluate further the role of Ni
in muscarinic-receptor-mediated phosphoinositide
hydrolysis. Our findings demonstrate that pertussis
toxin does not block muscarinic-receptor-mediated
stimulation of phosphoinositide hydrolysis, phos-
phatidylinositol synthesis or calcium mobilization.
It is concluded that muscarinic receptors do not
couple to phosphoinositide hydrolysis and calcium
mobilization through Ni.
Experimental
Heart cells were prepared from 13-day chick
embryos as described previously (Brown & Brown,
1984). Cells were suspended in Dulbecco's Eagle
medium containing 5% (v/v) foetal calf serum and
1% (v/v) Fungi-Bact (Irvine Scientific) and cul-
tured for 24h in 35mm culture dishes in an
atmosphere of air/CO2 (9:1). Astrocytoma cells
were grown as described previously (Meeker &
Harden, 1982; Masters et al., 1984).Pertussis toxin
was purified as described by Hughes et al. (1984)
and added to the culture medium 24 h before assay
of cyclic AMP formation, phosphoinositide hydro-
lysis, PtdIns synthesis or unidirectional 45Ca2+
efflux. All assays were carried out at 37°C in buffer
composed of 118mM-NaCl, 4.7mM-KCl, 1.8mM-
CaCl2, 1.2mM-MgSO4, 1.2mM-KH2PO4, 10mM-
glucose and 20mM-Hepes, pH 7.4. The buffer used
in experiments with astrocytoma cells was the
same except that it contained 3.0mM-CaCl2 and
0.5 mM-Na2EDTA.
For cyclic AMP assays, cultured heart cells were
treated with carbachol and isoprenaline for 2min,
the incubation was terminated by the addition of
10% (w/v) trichloroacetic acid, and cyclic AMP
was purified and assayed by the competitive
protein-binding assay as described previously
(Brown, 1979).
Cellular phosphoinositides were labelled by
incubating cells in growth medium with [3 H]inosi-
tol (1 uCi/ml) for 24h. Phosphoinositide hydrolysis
was monitored by measuring the accumulation of
[3H]InsP in the presence of 10mM-Li+, an inhibi-
tor of the phosphatase that converts InsP into
inositol (Berridge et al., 1982). Phospholipids were
extracted and the [3 H]InsP in the aqueous phase
was separated from [3 H]inositol by anion-ex-
change chromatography by a modification (Mas-
ters et al., 1984) of the method described by
Berridge et al. (1982).
In experiments in which Ptdlns synthesis was
studied, cells were washed free of growth medium
and labelled with 4pCi of [3H]inositol/ml for
60min. Vehicle or carbachol was then added for
various times, and the 3H incorporated into Ptdlns
was analysed as described previously (Masters et
al., 1984).
For unidirectional 45Ca2+-efflux assays, cell
monolayers were labelled to isotopic equilibrium
by incubation with growth medium containing
5pCi of 45CaC12/ml for 18-20h. The efflux assay
was initiated and terminated as described by
Masters et al. (1984). The rate constant was
calculated from the zero-time cellular 45Ca2+ and
the cellular 45Ca2+ present 0.5 min after the
addition of carbachol or vehicle. At this time the
unidirectional 45Ca2+ efflux rate approximates to a
first-order exponential with a single kinetic com-
ponent (Masters et al., 1984).
Results
Cyclic AMP formation in chick heart cells is
stimulated by the P-adrenergic-receptor agonist
isoprenaline. Isoprenaline-stimulated cyclic AMP
formation is inhibited by approx. 70% in the
presence of the cholinergic agonist carbachol
(Brown & Brown, 1984; see also Fig. 1). The
capacity of carbachol to inhibit cyclic AMP
formation was lost after pertussis-toxin treatment
(Fig. 1). This effect of pertussis toxin was concen-
tration-dependent and was maximal at lOOng/ml.
Pertussis toxin also caused a small increase in
isoprenaline-stimulated cyclic AMP formation
(Fig. 1).
In chick heart cells and 1321Ni astrocytoma
cells, muscarinic agonists stimulate phospho-
inositide hydrolysis, which results in the formation
of inositol tris-, bis- and mono-phosphates
(Masters et al., 1985). When cells are treated with
Li+, the inositol phosphates formed by phospho-
inositide hydrolysis accumulate as InsP. In chick
heart cells, pertussis-toxin treatment did not
decrease either basal or carbachol-stimulated InsP
formation under conditions in which the cyclic
AMP response was fully inhibited (Fig. 2). In
1321NI cells lOOng of pertussis toxin/ml fully
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Table 1. Pertussis toxin does not inhibit carbachol-stimulated InsPformation or 45Ca2+ efflux in 132JNJ astrocytoma cells
The accumulation of [3H]InsP was measured 0min after the addition of LiCl (basal) or LiCl and 100/LM-carbachol
(carbachol) to normal cells or to cells treated with pertussis toxin. The basal rate of unidirectional 45Ca2+ efflux and
that stimulated by 100upM-carbachol were determined as described in the Experimental section. The zero-time
45Ca2+ was 4518 + 104c.p.m. in normal cultures, 3853 + 58c.p.m. in cultures treated with lOng of pertussis toxin/ml,
and 3685 + 102c.p.m. in cultures treated with lOOng of pertussis toxin/ml. The zero-time 45Ca2+ in pertussis-toxin-
treated cultures was significantly different from that in normal cultures (P< 0.05) when effects were tested by one-
way analysis of variance and the Dunnett test. All values given are means + S.E.M. for four determinations.
[3H]InsP (c.p.m.) 45Ca2+ efflux rate (min 1)
Basal + Carbachol Increase Basal + Carbachol Increase
Control 392+ 2 1243+29 842 0.19+0.06 1.22+0.05 1.03
Pertussis toxin (lOng/ml) 362+ 10 1181 +40 819 0.19+0.07 1.06+0.04 0.87
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Fig. 1. Pertussis-toxin treatment blocks muscarinic inhibi-
tion of isoprenaline-stimulated cyclic AMP accumulation
Cultures of chick heart cells were treated for 24h
with various concentrations of pertussis toxin.
Isobutylmethylxanthine (100pm) was added to the
cells 20min before the addition of 3pM-isoprenaline
(0) or 3/M-isoprenaline plus lOpM-carbachol
(-). The basal cyclic AMP concentration (not
shown) was 5.3pmol/mg of protein. Values are
means + S.E.M. for four determinations.
ADP-ribosylates the a-subunit of Ni and function-
ally inactivates Ni (Evans et al., 1985; Hughes et
al., 1984). This concentration of toxin had no effect
on either basal or carbachol-stimulated [3 H]InsP
accumulation in 1321N 1 cells (Table 1). Thus
pertussis toxin does not block the muscarinic-
receptor-mediated increase in phosphoinositide
hydrolysis in either cell type.
To determine if PtdIns synthesis was inhibited
by pertussis toxin, the incorporation of [3H]inositol
into PtdIns was examined. Carbachol stimulated
[3H]inositol incorporation into Ptdlns in control
and pertussis-toxin-treated cells (Fig. 3). A very
small but significant (P<0.05) decrease in basal
and carbachol-stimulated [3 H]inositol incorpora-
tion was evident in pertussis-toxin-treated cells,
associated with a small (approx. 20%) but signifi-
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Fig. 2. Pertussis-toxin treatment does not affect stimula-
tion of InsPformation by carbachol in chick heart cells
Cultures of chick heart cells were treated for 24h
with various concentrations of pertussis toxin. The
accumulation of [3H]InsP was measured 30min
after the addition of LiCl (basal, 0) or LiCl and
00 jM-carbachol (0). Values are means +S.E.M. for
four determinations.
cant decrease in cellular free [3 H]inositol (c.p.m.).
We have previously shown that carbachol
stimulates unidirectional 45Ca2+ efflux from
1321N1 cells (Masters et al., 1984, 1985). Neither
the control nor the carbachol-stimulated rate of
45Ca2+ efflux from astrocytoma cells was affected
by pertussis-toxin treatment (Table 1). Both con-
centrations of pertussis toxin tested caused a slight
decrease in the zero-time cellular 45Ca2+ (see the
legend to Table 1).
Discussion
Pertussis toxin ADP-ribosylates Ni and blocks
the inhibition of adenylate cyclase mediated
through receptors that couple to this protein
(Katada & Ui, 1980; Hazeki & Ui, 1981; Kurose et
al., 1983; Gilman, 1984; Katada et al., 1984). Fain
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Time (min)
Fig. 3. Pertussis-toxin effects on [3H]inositol incorporation
into PtdIns
The radioactivity in Ptdlns in control (0, A) or
carbachol (lOOIsM)-treated cells (-, A) cultured in
the absence (0, 0) or presence (A, A) of lOOng of
pertussis toxin/ml is shown. The effect of pertussis
toxin on [3H]PtdIns was compared with controls by
two-way analysis of variance.
blocks hormonally stimulated PtdIns synthesis in
adipocytes from rats treated with this toxin
(Moreno et al., 1983). This led to the speculation
that Ni might also couple receptors to the
effector(s) involved in phosphoinositide meta-
bolism.
The initiating event in hormone-stimulated
PtdIns turnover is the hydrolysis of phospho-
inositides, and this in turn is followed by an
increase in the synthesis of phosphatidic acid and
PtdIns (Berridge, 1981; Michell & Kirk, 1981).
The studies described here demonstrate that
pertussis-toxin treatment does not block the hydro-
lysis of phosphoinositides stimulated through
muscarinic receptors in either chick heart or
1321 NI cells. Furthermore, pertussis-toxin treat-
ment has little effect on carbachol-stimulated
phosphoinositide synthesis, assessed by measuring
the incorporation of [3H]inositol into PtdIns. This
latter observation suggests that the inhibitory
effect of pertussis toxin on PtdIns synthesis in viw
(Moreno et al., 1983) does not result from a direct
effect of the toxin on phosphoinositide synthesis.
The failure of pertussis toxin to block muscar-
inic-receptor-mediated stimulation of phospho-
inositide hydrolysis in chick heart cells is instruc-
tive because the same concentrations of pertussis
toxin antagonize muscarinic inhibition of cyclic
AMP formation. This latter finding corroborates
that of Hazeki & Ui (1981) on rat heart cells and
indicates that pertussis toxin also affects Ni in
intact chick heart cells. These data also indicate
that the concentration range of pertussis toxin is
appropriate for uncoupling the muscarinic recep-
tor from Ni. Preliminary experiments measuring
[32 P]ADP-ribosylation of heart cell membranes
indicate that a pertussis-toxin substrate of the same
size as the a-subunit of Ni is present in the chick
heart cells and is fully ribosylated by treatment
with lOOng of pertussis toxin/ml.
1321N1 cells contain a 41 000-M, pertussis-toxin
substrate which has been shown to be ribosylated
at the concentrations of toxin used here (Hughes et
al., 1984). This protein appears to represent func-
tional Ni because guanine nucleotides inhibit
forskolin-activated adenylate cyclase in mem-
branes from these cells, and pertussis-toxin treat-
ment disrupts this function (Hughes et al., 1984).
Moreover, an adenosine receptor that couples
through Ni to inhibit adenylate cyclase has recently
been shown to be present in these cells (A. R.
Hughes & T. K. Harden, unpublished work).
Although Ni can apparently associate with the
adenylate cyclase in 1321Ni cells, it does not
couple the muscarinic receptor to adenylate cyclase
inhibition (Meeker & Harden, 1982). Several
studies have used pertussis toxin to demonstrate
that Ni mediates hormone-induced calcium mobi-
lization in neutrophils (Molski et al., 1984;
Okajima & Ui, 1984; Bokoch et al., 1984). In
contrast, our finding that pertussis toxin does not
affect muscarinic-receptor-stimulated [3 H]InsP
formation or unidirectional 45Ca2+ efflux indicates
that the Ni present in 1321 NI cells does not couple
the muscarinic receptor to either phosphoinositide
hydrolysis or calcium mobilization.
Although it does not appear that Ni couples
muscarinic receptors to the effectors for phospho-
inositide turnover and calcium mobilization, these
responses may be mediated through a guanine
nucleotide regulatory protein whose function is not
inhibited by pertussis toxin. Muscarinic receptors
in membranes from 1321 NI cells express GTP-
sensitive high-affinity binding of carbachol, which
is not affected by pertussis toxin (Evans et al.,
1985). In addition, the extent of guanine nucleo-
tide-sensitive high-affinity binding of cholinergic
agonists corresponds with the relative efficacy of
these agonists for stimulation of phosphoinositide
hydrolysis and Ca2+ mobilization (Hepler et al.,
1984). Thus there is evidence for a muscarinic-
receptor-guanine nucleotide regulatory protein
interaction in these cells, but, on the basis of the
effect of pertussis toxin on binding and on the func-
tional responses to cholinergic agonists examined
here, this protein does not appear to be N1. The
identity of this putative protein and its possible
role in regulation of phosphoinositide and calcium
metabolism are subjects of considerable interest.
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